Dale Umetsu
Physician · BLUEMARK LLC OFFICE ALLY
Credentials: · · · ·
History
- Present
BLUEMARK LLC OFFICE ALLY · UCSF OUTPATIENT PHARMACY AT PARNASSUS
1981–1984

Research
Nature Immunology · 2001 · Last of 3 authors · 910 citations
Extrathymically generated regulatory T cells control mucosal TH2 inflammation
Nature · 2012 · 686 citations
Nature Immunology · 2011 · Last of 8 authors · 682 citations
- RG
20 papers

13 papers

13 papers

10 papers
- LS
10 papers
- RR
10 papers

10 papers · 2 as a resident

8 papers
Grants
- 2003–2017
TIM Recognition of Phosphatidylserine Regulates Innate and Adaptive Immunity
National Institute of Allergy and Infectious Diseases · P01
Contact PI · $11.6M · Dana-Farber Cancer Inst
- 2012–2014
New England Regional Center of Excellence in Biodefense and Emerging Infectious D
National Institute of Allergy and Infectious Diseases · U54
Project lead · $169.4K · Harvard Medical School
- 2010–2013
Peanut Glycolipid Antigens Activate Natural Killer T Cells Causing Severe Allergy
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $438.1K · Boston Children's Hospital
- 2009–2012
Recognition of Microbes by NKT Cells at the Lung Mucosal Surface
National Heart, Lung, and Blood Institute · RC1
Contact PI · $757.5K · Boston Children's Hospital
Clinical trials
- 2009–2017
Xolair Treatment for Milk Allergic Children
Principal investigator · Completed · Early phase 1
Boston Children's Hospital
